{"id":"https://openalex.org/W7208806752","doi":"https://doi.org/10.2174/0118722105421253260515204927","title":"Micro Novel Carriers: Reshaping Tuberculosis Therapy by Targeting Alveolar Macrophages, Reducing Drug Resistance, and Shortening Treatment Durations-A 2020-2025 Comprehensive Review","display_name":"Micro Novel Carriers: Reshaping Tuberculosis Therapy by Targeting Alveolar Macrophages, Reducing Drug Resistance, and Shortening Treatment Durations-A 2020-2025 Comprehensive Review","publication_year":2026,"publication_date":"2026-09-02","ids":{"openalex":"https://openalex.org/W7208806752","doi":"https://doi.org/10.2174/0118722105421253260515204927"},"language":"en","primary_location":{"id":"doi:10.2174/0118722105421253260515204927","doi":"https://doi.org/10.2174/0118722105421253260515204927","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118722105421253260515204927","pdf_url":null,"source":{"id":"https://openalex.org/S171866559","display_name":"Recent Patents on Nanotechnology","issn_l":"1872-2105","issn":["1872-2105","2212-4020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Nanotechnology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101142656","display_name":"Sakshi Verma","orcid":"https://orcid.org/0009-0007-7267-8848","observed_orcids":["https://orcid.org/0009-0007-7267-8848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakshi Verma","raw_affiliation_strings":["Department of Pharmacy, Usha Martin University, Ranchi, Jharkhand, 835103, India"],"raw_orcid":"https://orcid.org/0009-0007-7267-8848","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Usha Martin University, Ranchi, Jharkhand, 835103, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150312936","display_name":"Dipanshu Panday","orcid":"https://orcid.org/0009-0007-3641-4888","observed_orcids":["https://orcid.org/0009-0007-3641-4888"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dipanshu Panday","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, T.S. Mishra Medical University, Lucknow, 226008, UP, India"],"raw_orcid":"https://orcid.org/0009-0007-3641-4888","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, T.S. Mishra Medical University, Lucknow, 226008, UP, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114850515","display_name":"A. V. Vasanthi","orcid":"https://orcid.org/0009-0006-8006-7361","observed_orcids":["https://orcid.org/0009-0006-8006-7361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.V. Vasanthi","raw_affiliation_strings":["Department of Pharmacy, Sarojini Naidu Vanita Pharmacy Maha Vidyalaya, Tarnaka, Secunderabad, Telangana, 500017, India"],"raw_orcid":"https://orcid.org/0009-0006-8006-7361","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sarojini Naidu Vanita Pharmacy Maha Vidyalaya, Tarnaka, Secunderabad, Telangana, 500017, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060666059","display_name":"Subhashree Sahoo","orcid":"https://orcid.org/0009-0009-6835-1337","observed_orcids":["https://orcid.org/0009-0009-6835-1337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Subhashree Sahoo","raw_affiliation_strings":["Department of Pharmacy, Usha Martin University, Ranchi, Jharkhand, 835103, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Usha Martin University, Ranchi, Jharkhand, 835103, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150113583","display_name":"Roli","orcid":"https://orcid.org/0009-0006-2182-0683","observed_orcids":["https://orcid.org/0009-0006-2182-0683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roli","raw_affiliation_strings":["Department of Pharmaceutics, Asian International University, Imphal, Ghari, Manipur, 795140, India"],"raw_orcid":"https://orcid.org/0009-0006-2182-0683","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Asian International University, Imphal, Ghari, Manipur, 795140, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150109765","display_name":"Anjali Yadav","orcid":"https://orcid.org/0009-0001-0663-9986","observed_orcids":["https://orcid.org/0009-0001-0663-9986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anjali Yadav","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Asian International University, Imphal, Ghari, Manipur, 795140, India"],"raw_orcid":"https://orcid.org/0009-0001-0663-9986","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Asian International University, Imphal, Ghari, Manipur, 795140, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111419780","display_name":"Bimal C. Ghosh","orcid":"https://orcid.org/0009-0009-1034-1486","observed_orcids":["https://orcid.org/0009-0009-1034-1486"]},"institutions":[{"id":"https://openalex.org/I74319210","display_name":"Chitkara University","ror":"https://ror.org/057d6z539","country_code":"IN","type":"education","lineage":["https://openalex.org/I74319210"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Binita Ghosh","raw_affiliation_strings":["Department of Pharmacy Practice, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"],"raw_orcid":"https://orcid.org/0009-0009-1034-1486","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India","institution_ids":["https://openalex.org/I74319210"]}]},{"author_position":"last","author":{"id":null,"display_name":"Rahul Pal","orcid":"https://orcid.org/0000-0003-2062-2678","observed_orcids":["https://orcid.org/0000-0003-2062-2678"]},"institutions":[{"id":"https://openalex.org/I74319210","display_name":"Chitkara University","ror":"https://ror.org/057d6z539","country_code":"IN","type":"education","lineage":["https://openalex.org/I74319210"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Rahul Pal","raw_affiliation_strings":["Department of Pharmaceutics, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"],"raw_orcid":"https://orcid.org/0000-0003-2062-2678","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India","institution_ids":["https://openalex.org/I74319210"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I74319210"],"apc_list":null,"apc_paid":null,"fwci":3.5869,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.85498186,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"20","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.30300000309944153,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.09719999879598618,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-delivery-systems","display_name":"drug delivery systems","score":0.7720000147819519},{"id":"https://openalex.org/keywords/alveolar-macrophages","display_name":"alveolar macrophages","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7160000205039978},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.8809999823570251},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":1.0},{"id":"https://openalex.org/keywords/microspheres","display_name":"microspheres","score":0.9319999814033508},{"id":"https://openalex.org/keywords/microcapsules","display_name":"microcapsules","score":0.9739999771118164},{"id":"https://openalex.org/keywords/microemulsions","display_name":"microemulsions","score":0.9359999895095825},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8159999847412109},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7245000004768372},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6868000030517578},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.6398000121116638},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5619000196456909},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.5364999771118164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4839000105857849},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.4823000133037567},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4271000027656555},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.42239999771118164},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.41600000858306885},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.3986000120639801},{"id":"https://openalex.org/C176999471","wikidata":"https://www.wikidata.org/wiki/Q6839314","display_name":"Microcarrier","level":3,"score":0.3375000059604645},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.3285999894142151},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2922999858856201},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2831000089645386}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/0118722105421253260515204927","doi":"https://doi.org/10.2174/0118722105421253260515204927","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118722105421253260515204927","pdf_url":null,"source":{"id":"https://openalex.org/S171866559","display_name":"Recent Patents on Nanotechnology","issn_l":"1872-2105","issn":["1872-2105","2212-4020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Nanotechnology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2988327168","https://openalex.org/W7151825661","https://openalex.org/W4387048319","https://openalex.org/W7161551232","https://openalex.org/W4368374137","https://openalex.org/W4220662622","https://openalex.org/W7172352508","https://openalex.org/W7202163083","https://openalex.org/W7164681907","https://openalex.org/W4414182642"],"abstract_inverted_index":{"Introduction:":[0],"This":[1],"review":[2,78],"evaluates":[3],"micro":[4],"novel":[5],"carriers":[6,150,306],"(MNCs)":[7],"like":[8,83],"microspheres,":[9],"microcapsules,":[10],"microparticles,":[11],"microemulsions,":[12],"and":[13,27,48,70,88,115,136,160,175,188,213,225,235,243,248,261,267,286,300,304,313,318,327,354],"lipid-based":[14],"microparticles":[15,177],"for":[16,68,104,141,168,172,178,229,337],"enhancing":[17],"Tuberculosis":[18],"(TB)":[19],"treatment":[20,220,293,343],"by":[21,33,154,254,295],"improving":[22,155,296],"drug":[23,29,46,50,72,152,297],"targeting,":[24],"reducing":[25],"toxicity,":[26],"combating":[28],"resistance.":[30],"TB,":[31],"caused":[32],"Mycobacterium":[34],"tuberculosis":[35],"(Mtb),":[36],"remains":[37],"a":[38,334],"global":[39],"health":[40],"challenge":[41],"due":[42],"to":[43,100,209,258,349],"lengthy":[44],"treatment,":[45],"resistance,":[47],"limited":[49],"access.":[51],"Conventional":[52],"treatments":[53],"may":[54],"not":[55],"reach":[56],"effective":[57],"levels":[58],"at":[59],"the":[60,64,95,110,122,199,211,230,259],"infection":[61],"site,":[62],"necessitating":[63],"development":[65],"of":[66,90,125,133,198,232,281],"microcarriers":[67,250],"precise":[69],"potent":[71],"delivery.":[73],"Methodology:":[74],"A":[75],"comprehensive":[76],"literature":[77],"was":[79],"conducted":[80],"using":[81],"databases":[82],"Pub-":[84],"Med/PMC,":[85],"Scopus,":[86],"ScienceDirect,":[87],"Web":[89],"Science":[91],"covering":[92],"research":[93,146,346],"from":[94],"past":[96],"5":[97],"years":[98],"(2020":[99],"2025).":[101],"The":[102,145],"criteria":[103],"selection":[105],"included":[106],"studies":[107],"focused":[108],"on":[109],"formulation,":[111],"characterization,":[112],"in":[113,116,128,182,192,279,356],"vitro":[114],"vivo":[117],"assessments,":[118],"as":[119,121],"well":[120],"clinical":[123,134,269,319],"significance":[124],"innovative":[126,149],"MNCs":[127,205,289,332],"TB":[129,219,292,339],"treatment.":[130],"Additionally,":[131,265],"reviews":[132],"trials":[135],"patent":[137],"information":[138],"were":[139],"incorporated":[140],"translational":[142],"understanding.":[143],"Results:":[144],"indicated":[147],"that":[148,204],"enhance":[151,307],"delivery":[153,257],"pharmacokinetics,":[156],"targeting":[157],"alveolar":[158],"macrophages,":[159,255],"facilitating":[161],"controlled":[162],"release.":[163,245,302],"Recent":[164],"developments":[165],"feature":[166],"microspheres":[167],"isoniazid":[169],"(INH),":[170],"microcapsules":[171],"rifampicin":[173],"(RIF),":[174],"lipid-core":[176],"various":[179],"medications,":[180,238],"resulting":[181],"improved":[183],"bioavailability,":[184],"less":[185],"frequent":[186],"dosing,":[187],"minimized":[189,262],"side":[190],"effects":[191],"preclinical":[193],"evaluations.":[194],"Discussion:":[195],"An":[196],"analysis":[197],"existing":[200],"evidence":[201],"has":[202],"shown":[203],"possess":[206],"considerable":[207],"potential":[208],"overcome":[210,291],"pharmacological":[212],"therapeutic":[214],"challenges":[215,294],"associated":[216],"with":[217],"current":[218],"regimens.":[221],"Their":[222],"distinct":[223],"structural":[224],"compositional":[226],"diversity":[227],"allows":[228],"encapsulation":[231],"both":[233],"hydrophilic":[234],"lipophilic":[236],"anti-TB":[237],"which":[239],"improves":[240],"stability,":[241,298],"solubility,":[242,299],"prolonged":[244],"Furthermore,":[246],"ligand-functionalized":[247],"inhalable":[249,305],"exhibit":[251],"enhanced":[252],"uptake":[253],"targeted":[256,310,338],"lungs,":[260],"systemic":[263,315],"toxicity.":[264,316],"patents":[266],"new":[268],"trial":[270],"findings":[271],"underscore":[272],"their":[273,322,351],"practical":[274],"applicability,":[275,323],"although":[276],"obstacles":[277],"persist":[278],"terms":[280],"large-scale":[282,325],"manufacturing,":[283],"regulatory":[284,328],"approval,":[285],"cost-effectiveness.":[287],"Conclusion:":[288],"can":[290],"sustained":[301],"Ligand-functionalized":[303],"macrophage":[308],"uptake,":[309],"lung":[311],"delivery,":[312],"reduce":[314],"Patents":[317],"data":[320],"support":[321],"though":[324],"production":[326],"approval":[329],"remain":[330],"challenges.":[331],"offer":[333],"promising":[335],"platform":[336],"therapy,":[340],"overcoming":[341],"conventional":[342],"drawbacks.":[344],"Further":[345],"is":[347],"needed":[348],"confirm":[350],"safety,":[352],"scalability,":[353],"effectiveness":[355],"human":[357],"populations.":[358]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-09-06T00:00:00"}